Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eder

Showing results (251-260 of 283) with videos related to

Pageof 29
Sort By:
Molecular Psychiatry|March 2, 2021
The co-chaperone Fkbp5 shapes the acute stress response in the paraventricular nucleus of the hypothalamus of male miceAlexander S Häusl, Lea M Brix, Jakob Hartmann, et al.
Bone Marrow Transplantation|November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMatjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Bone Marrow Transplantation|May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMTAnnalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Haematologica|June 19, 2025
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i> haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationLin Li, Yishan Ye, Jacques-Emmanuel Galimard, et al.
American Journal of Hematology|November 28, 2024
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMTThomas Luft, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Bone Marrow Transplantation|July 2, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemiaAlexandros Spyridonidis, Allain Thibeault Ferhat, Jacques Emmanuel Galimard, et al.
Bone Marrow Transplantation|November 29, 2025
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working PartyMarta Villalba, Allain-Thibeault Ferhat, Tobias Gedde-Dahl, et al.
Pageof 29

Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Molecular Psychiatry|March 2, 2021
The co-chaperone Fkbp5 shapes the acute stress response in the paraventricular nucleus of the hypothalamus of male miceAlexander S Häusl, Lea M Brix, Jakob Hartmann, et al.
Bone Marrow Transplantation|November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMatjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Bone Marrow Transplantation|May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMTAnnalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Haematologica|June 19, 2025
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i> haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationLin Li, Yishan Ye, Jacques-Emmanuel Galimard, et al.
American Journal of Hematology|November 28, 2024
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMTThomas Luft, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Bone Marrow Transplantation|July 2, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemiaAlexandros Spyridonidis, Allain Thibeault Ferhat, Jacques Emmanuel Galimard, et al.
Bone Marrow Transplantation|November 29, 2025
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working PartyMarta Villalba, Allain-Thibeault Ferhat, Tobias Gedde-Dahl, et al.
Pageof 29